Involvement of tryptase-related cellular protease(s) in human immunodeficiency virus type 1 infection.
about
Identification of the U-937 membrane-associated proteinase interacting with the V3 loop of HIV-1 gp120 as cathepsin GPathogenesis of human immunodeficiency virus infectionThe complete Consensus V3 loop peptide of the envelope protein gp120 of HIV-1 shows pronounced helical character in solutionSecretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitroAntiviral and pharmacokinetic properties of C2 symmetric inhibitors of the human immunodeficiency virus type 1 proteaseInhibition of human immunodeficiency virus type 1 infection and syncytium formation in human cells by V3 loop synthetic peptides from gp120Human immunodeficiency virus type 1 envelope glycoprotein molecules containing membrane fusion-impairing mutations in the V3 region efficiently undergo soluble CD4-stimulated gp120 release.The anti-HIV-1 activity associated with saliva.Proteinase-resistant factors in human erythrocyte membranes mediate CD4-dependent fusion with cells expressing human immunodeficiency virus type 1 envelope glycoproteinsMediation of human immunodeficiency virus type 1 binding by interaction of cell surface heparan sulfate proteoglycans with the V3 region of envelope gp120-gp41.A role for urokinase-type plasminogen activator in human immunodeficiency virus type 1 infection of macrophages.A complementarity-determining region synthetic peptide acts as a miniantibody and neutralizes human immunodeficiency virus type 1 in vitro.Enhanced in vitro human immunodeficiency virus type 1 replication in B cells expressing surface antibody to the TM Env protein.Alteration of V3 loop context within the envelope of human immunodeficiency virus type 1 enhances neutralizationFactors involved in entry of the human immunodeficiency virus type 1 into permissive cells: lack of evidence of a role for CD26.Human immunodeficiency virus type 1 envelope gp120 is cleaved after incubation with recombinant soluble CD4Analysis of mutations in the V3 domain of gp160 that affect fusion and infectivity.The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection.Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism.Identification of the principal neutralizing determinant of human immunodeficiency virus type 1 as a fusion domain.Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule.Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.HIV-neutralizing antibodies: epitope identification and significance for future vaccine.Conformational features of a synthetic cyclic peptide corresponding to the complete V3 loop of the RF HIV-1 strain in water and water/trifluoroethanol solutions.Identification of human immunodeficiency virus envelope gene sequences influencing viral entry into CD4-positive HeLa cells, T-leukemia cells, and macrophages.Host range, replicative, and cytopathic properties of human immunodeficiency virus type 1 are determined by very few amino acid changes in tat and gp120Replication of patient isolates of human immunodeficiency virus type 1 in T cells: a spectrum of rates and efficiencies of entrySmall amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell-line and macrophage tropism of human immunodeficiency virus type 1.Identification of a determinant within the human immunodeficiency virus 1 surface envelope glycoprotein critical for productive infection of primary monocytes.Early events of HIV infection as targets for antiviral agents.T-cell membrane-associated serine protease, tryptase TL2, binds human immunodeficiency virus type 1 gp120 and cleaves the third-variable-domain loop of gp120. Neutralizing antibodies of human immunodeficiency virus type 1 inhibit cleavage of gp120.Role of cell surface glycosaminoglycans of human T cells in human immunodeficiency virus type-1 (HIV-1) infection.Isolation and characterization of human immunodeficiency virus type 1 variants infectious to brain-derived cells: detection of common point mutations in the V3 region of the env gene of the variants.The region of the envelope gene of human immunodeficiency virus type 1 responsible for determination of cell tropism.Dextran sulfate blocks antibody binding to the principal neutralizing domain of human immunodeficiency virus type 1 without interfering with gp120-CD4 interactions.Complementation of murine cells for human immunodeficiency virus envelope/CD4-mediated fusion in human/murine heterokaryons.Mutations in the principal neutralization determinant of human immunodeficiency virus type 1 affect syncytium formation, virus infectivity, growth kinetics, and neutralization.Human immunodeficiency virus type 1 entry into T cells: more-rapid escape from an anti-V3 loop than from an antireceptor antibody.Separation and partial characterization of proteinases with substrate specificity for basic amino acids from human MOLT-4 T lymphocytes: identification of those inhibited by variable-loop-V3 peptides of HIV-1 (human immunodeficiency virus-1) envelopInteraction between a membrane-associated serine proteinase of U-937 monocytes and peptides from the V3 loop of the human immunodeficiency virus type 1 (HIV-1) gp120 envelope glycoprotein.
P2860
Q24315636-550719D6-97FF-418B-B2E5-8608308D60E9Q24634681-8B682350-7F6C-4D13-A0F8-574FDDDF1FDCQ27729741-25058388-6DFC-4DAA-9A18-346D3A869DB8Q28293679-06BA44F5-DE4B-4CDB-86E7-CB66E07894C2Q28325705-BB7FF543-5932-47B0-B4CF-D170A8CE4865Q28368050-BC19BF08-C2F9-4E2F-925A-E6EAB7C68FCEQ33720162-138AA4E4-B790-4F1E-85EE-BC77BE47EB59Q34738486-F4AD75EE-53AD-44A8-BB2C-5AD873DD6821Q35832208-0241336B-EEE3-4BC8-9A4F-2EE94493989BQ35837553-DDC8BCAD-FBC2-4C8F-A5E8-7FEC167C5E5EQ35864006-212BFF6B-393E-4F21-BD93-371BE25C986AQ36295519-7D61829F-5F59-4B22-9A34-CF8D3C653F28Q36630413-2CFE96C6-7D1B-45D9-B8DF-FB951AEF0B26Q36633911-755CC9B4-D4D6-49F7-A1CB-0BC180BCC01EQ36636241-12558199-96EA-4A61-A336-FE87ADD88D5BQ36645175-DDDE4F31-8C06-4FE9-9890-AA6D84AC9A41Q36656386-ABC9F412-1E2A-4008-843B-0E5B602CE1C3Q36669879-A7606EFE-5770-4986-B707-27EAA570672EQ36685201-8B04345A-9B57-40D9-972C-0CAB03CC0884Q36687883-94085A40-65EF-47A6-B219-2BED6922665FQ36697652-75C11519-3EB7-4A7A-A440-C2ED7189BEB4Q36702147-D40EFBD2-6ADB-43BD-B1CD-6D1771FDE8C5Q36708990-C5E90714-8E3E-44D3-922F-3D599419599DQ36797568-B1E1EA33-8E54-44C8-A564-822BD8D93482Q36820658-0C67E5F0-95EE-4E5E-971D-1DD1ABE99331Q36828914-D49A21F6-617A-459E-BCC3-756F7C7D3032Q36889165-5D6DCB52-49A7-4F3F-84C4-09B1497604A9Q37239053-2608D6D4-6EAC-4E35-AA4F-DE478510682DQ37476959-048D358E-6DB5-4EA0-B780-F867230E0603Q37783033-13B18C50-8049-4A57-B346-C9D1138679C7Q38359834-77FC7C78-1C4E-4A02-95AF-F39B9ED1B1C2Q39318713-922F8BB7-C9DA-4DD2-98D9-3F717D702D74Q39457849-2505EDD1-3655-4D29-8809-C13A85DF9FDAQ40049070-64650ECA-293F-48A6-8D13-AF55906F64DFQ40059624-B8CFC669-A568-42D6-9C8E-DE18A11B3193Q40066675-745181C9-6A7D-4BC5-8E72-19AE760CA431Q40308489-D3944BA6-2AE6-4B2B-AE40-C6A0E5EC4317Q40308952-2200F400-EFD2-495A-9826-E2717DBCB18BQ41547625-083E23E8-54FC-4355-B4B5-2F164EEFBFA9Q41573921-0375BE6F-76A5-4068-8221-9EF0CAFAEB64
P2860
Involvement of tryptase-related cellular protease(s) in human immunodeficiency virus type 1 infection.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh-hant
name
Involvement of tryptase-related cellular protease
@nl
Involvement of tryptase-relate ...... ciency virus type 1 infection.
@en
type
label
Involvement of tryptase-related cellular protease
@nl
Involvement of tryptase-relate ...... ciency virus type 1 infection.
@en
prefLabel
Involvement of tryptase-related cellular protease
@nl
Involvement of tryptase-relate ...... ciency virus type 1 infection.
@en
P2093
P2860
P1433
P1476
Involvement of tryptase-relate ...... ciency virus type 1 infection.
@en
P2093
P2860
P356
10.1016/0014-5793(89)80429-6
P407
P577
1989-05-01T00:00:00Z